|
[1]
|
Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice[J]. Nature, 2009,460(7253):392. |
|
[2]
|
Spilman P, Podlutskaya N, Hart MJ, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease[J]. PLoS One, 2010,5(4):e9979. |
|
[3]
|
Zhai XZ, Yao YM, Wang SH, et al. Activation of signal transducer and activator of transcription 3 in multiple organs of rats with sepsis[J]. Chin J Trauma, 2004,20(3):146. |
|
[4]
|
姚 胜,姚咏明,李红云,等. 雷帕霉素对烫伤后金黄色葡萄球菌脓毒症大鼠白细胞介素[J].中华急诊医学杂志,2006,15(1):34. |
|
[5]
|
Krakauer T, Buckley M, Issaq HJ, et al. Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo[J]. Antimicrob Agents Chemother, 2010,54(3):1125. |
|
[6]
|
Huang S, Houghton PJ. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic[J]. Curr Opinion Invest Drugs, 2002,3(2):295. |
|
[7]
|
Jiang BH, Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis[J]. Adv Cancer Res, 2009,102:19. |
|
[8]
|
Strimpakos AS, Syrigos KN, Saif MW. The molecular targets for the diagnosis and treatment of pancreatic cancer [J]. Gut Liver, 2010,4(4):433. |
|
[9]
|
Sedrani R, Cotterns S, Kallen J. Chemical modification of rapamycin: the discovery of SDZ RAD[J]. Transplant Proc,1998,30(5):2192. |
|
[10]
|
Merimsky O, Jiveliouk I, Sagi-Eisenberg R. Targeting mTOR in HIV-Negative Classic Kaposi's Sarcoma[J]. Sarcoma, 2008,2008:825093. |
|
[11]
|
Tsai MK, Wu FL, Lai IR, et al. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy[J]. Int J Artif Organs, 2009, 32(6):371. |
|
[12]
|
张全胜, 史 瑞, 刘懿禾. 肝移植术后西罗莫司致间质性肺炎[J]. 中国危重病急救医学, 2010, 7:436. |
|
[13]
|
Josep MC. Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors[J]. Transplant Rev, 2008,22(1):73. |
|
[14]
|
Fukuda D, Sata M, Tanaka K, et al. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells[J]. Circulation, 2005,111(7):926. |
|
[15]
|
Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, et al. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial[J]. Eur Heart J, 2007,28(16):1946. |
|
[16]
|
Ma KL, Ruan XZ, Powis SH, et al. Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells[J]. Am J Physiol Heart Circ Physiol, 2007,292(6):H2721. |
|
[17]
|
Lee CH, Inoki K, Guan KL. mTOR pathway as a target in tissue hypertrophy[J]. Annu Rev Pharmacol Toxicol, 2007,47:443. |
|
[18]
|
Kuzman JA, OConnell TD, Gerdes AM. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy[J]. Endocrinology, 2007,148(7):3477. |
|
[19]
|
Soesanto W, Lin HY, Hu E, et al. Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats[J]. Hypertension,2009,54(6):1321. |
|
[20]
|
Steiner JP, Connolly MA, Valentine HL, et al. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin, and cyclosporine A[J]. Nat med ,1997,3(4):421. |
|
[21]
|
Ruan B, Pong K, Jow F, et al. Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activitie[J]. Proc Natl Acad Sci USA, 2008,105(1):33. |
|
[22]
|
Qi H, Chen Y, Fu X, et al. TOR regulates cell death induced by telomere dysfunction in budding yeast[J]. PLoS One, 2008,3(10):e3520. |
|
[23]
|
Liu S, Lu B. Reduction of protein translation and activation of autophagy protect against PINK1 pathogenesis in Drosophila melanogaster[J]. PLoS Genet, 2010,6(12):e1001237. |
|
[24]
|
Bjedov I, Toivonen JM, Kerr F, et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster[J]. Cell Metab, 2010,11(1):35. |
|
[25]
|
Malagelada C, Jin ZH, Jackson-Lewis V, et al. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease[J]. J Neurosci, 2010,30(3):1166. |
|
[26]
|
Ponseti JM, Azem J, Fort JM, et al. Long-term results of tacrolimus in cyclosporineand prednisone-dependent myasthenia gravis[J]. Neurology, 2005,64(9):1641. |
|
[27]
|
Phornphutkul C, Lee M, Voigt C, et al. The effect of rapamycin on bone growth in rabbits[J]. J Orthop Res, 2009,27(9):1157. |
点击查看大图
下载:
